Clinical Trial Update: DEP-Ru Regimen as a Salvage Therapy for HLH [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the DEP-Ru regimen as salvage therapy for hemophagocytic lymphohistiocytosis is ongoing. The current trial status is not dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• DEP-Ru Regimen

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Hemophagocytic Lymphohistiocytosis | Phase 3 | Status: UNKNOWN